The global non-metastatic prostate cancer treatment market is a rapidly evolving sector within the healthcare industry. Driven by an elevating prevalence of prostate cancer, coupled with advancements in diagnostic technologies, this market is poised for significant growth. Major players in the market are actively researching new therapies and treat